000 01740 a2200481 4500
005 20250513235348.0
264 0 _c20010830
008 200108s 0 0 eng d
022 _a0143-3636
024 7 _a10.1097/00006231-200103000-00002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVan De Wiele, C
245 0 0 _a99Tc(m) labelled HL91 versus computed tomography and biopsy for the visualization of tumour recurrence of squamous head and neck carcinoma.
_h[electronic resource]
260 _bNuclear medicine communications
_cMar 2001
300 _a269-75 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBiopsy
650 0 4 _aCarcinoma, Squamous Cell
_xdiagnostic imaging
650 0 4 _aHead and Neck Neoplasms
_xdiagnostic imaging
650 0 4 _aHumans
650 0 4 _aImage Processing, Computer-Assisted
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
_xdiagnostic imaging
650 0 4 _aOrganotechnetium Compounds
_xadverse effects
650 0 4 _aOximes
_xadverse effects
650 0 4 _aPilot Projects
650 0 4 _aRadiography
650 0 4 _aRadiopharmaceuticals
_xadverse effects
650 0 4 _aReproducibility of Results
650 0 4 _aSafety
650 0 4 _aTomography, Emission-Computed
700 1 _aVersijpt, J
700 1 _aDierckx, R A
700 1 _aMoerman, M
700 1 _aLemmerling, M
700 1 _aD'Asseler, Y
700 1 _aVermeersch, H
773 0 _tNuclear medicine communications
_gvol. 22
_gno. 3
_gp. 269-75
856 4 0 _uhttps://doi.org/10.1097/00006231-200103000-00002
_zAvailable from publisher's website
999 _c11249159
_d11249159